Behavior Enhances Drug Reduction of Incontinence (BE-DRI)

NCT00090584 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

307

Enrollment

OTHER

Sponsor class

Conditions

Urinary Incontinence (UI)

Interventions

DRUG: Tolterodine
BEHAVIORAL: Behavioral training

Sponsor

Carelon Research

Collaborators

[object Object]